Transdermal delivery of drugs with microneedles: Strategies and outcomes

Journal of Drug Delivery Science and Technology

Volumn 29, Issue , 2015, Pages 16-23

  Ita, Kevin ^a  

^a TOURO UNIVERSITY CALIFORNIA   (United States)

Author keywords

Clinical trials; Drug delivery; Microneedles; Outcomes; Strategies; Transdermal

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; CAPTOPRIL; CISPLATIN; CURCUMIN; FLUOROURACIL; METOPROLOL TARTRATE; PARATHYROID HORMONE[1-34]; PENETRATION ENHANCING AGENT; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; DERMIS; DRUG RELEASE; ENHANCER REGION; HUMAN; IONTOPHORESIS; MICRONEEDLE; NANOFABRICATION; NONHUMAN; PAIN RECEPTOR; RAT; REVIEW; SKIN PENETRATION; STRATUM CORNEUM; TRANSDERMAL DRUG DELIVERY SYSTEM;

EID: 84939791243     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2015.05.001     Document Type: Review

References (76)

1. J. Hadgraft, Passive enhancement strategies in topical and transdermal drug delivery, Int. J. Pharm. 184 (1) (1999) 1-6.
2. M.B. Delgado-Charro, R.H. Guy, Effective use of transdermal drug delivery in children, Adv. Drug Deliv. Rev. 73 (0) (2014) 63e82.
3. J. Levin, H. Maibach, Interindividual variation in transdermal and oral drug deliveries, J. Pharm. Sci. 101 (11) (2012) 4293-4307.
4. J. du Plessis, et al., Physico-chemical determinants of dermal drug delivery: effects of the number and substitution pattern of polar groups, Eur. J. Pharm. Sci. 16 (3) (2002) 107e112.
5. K.B. Ita, Transdermal drug delivery: progress and challenges, J. Drug Deliv. Sci. Technol. 24 (3) (2014) 245-250.
6. T.F. Wang, G.B. Kasting, J.M. Nitsche, A multiphase microscopic diffusion model for stratum corneum permeability. I. Formulation, solution, and illustrative results for representative compounds, J. Pharm. Sci. 95 (3) (2006) 620-648.
7. M. Martins, et al., In vitro and computational studies of transdermal perfusion of nanoformulations containing a large molecular weight protein, Colloids Surf. B Biointerfaces 108 (2013) 271-278.
8. J.A. Bouwstra, et al., Structure of the skin barrier and its modulation by vesicular formulations, Prog. Lipid Res. 42 (1) (2003) 1-36.
9. B. Ongpipattanakul, M.L. Francoeur, R.O. Potts, Polymorphism in stratum corneum lipids, Biochim. Biophys. Acta 1190 (1) (1994) 115-122.
10. C.L. Gay, et al., Characterization of low-temperature (i.e., < 65 degrees C) lipid transitions in human stratum corneum, J. Invest Dermatol. 103. 2, 1994. 233-239
11. M.J. Uddin, N. Scoutaris, P. Klepetsanis, B. Chowdhry, M.R. Prausnitz, D. Douroumis, Inkjet printing of transdermal microneedles for the delivery of anticancer agents, Int. J. Pharm. (2015 Jan 21), http://dx.doi.org/10.1016/ j.ijpharm.2015.01.038 (Epub ahead of print).
12. Y.A. Gomaa, et al., Microneedle/nanoencapsulation-mediated transdermal delivery: mechanistic insights, Eur. J. Pharm. Biopharm. 86 (2) (2014) 145-155.
13. K.S. Kim, K. Ita, L. Simon, Modelling of dissolving microneedles for transdermal drug delivery: theoretical and experimental aspects, Eur. J. Pharm. Sci. 68 (0) (2015) 137-143.
14. R.F. Donnelly, et al., Hydrogel-forming microneedles prepared from "super swelling" polymers combined with lyophilised wafers for transdermal drug delivery, PLoS One 9 (10) (2014) e111547.
15. J.A. Eldridge, et al., Synthesis and in vitro stability of amino acid prodrugs of 6- b-naltrexol for microneedle-enhanced transdermal delivery, Bioorg. Med. Chem. Lett. 24 (22) (2014) 5212-5215.
16. Sebastien Henry, D.V. M., Mark G. Allen, Mark R. Prausnitz, Microfabricated microneedles: a novel approach to transdemal drug delivery, J. Pharm. Sci. 87 (8) (1998) 922-925.
17. M. Kaur, et al., Microneedle-assisted delivery of verapamil hydrochloride and amlodipine besylate, Eur. J. Pharm. Biopharm. 86 (2) (2014) 284-291.
18. K.S. Kim, K. Ita, L. Simon, Modelling of dissolving microneedles for transdermal drug delivery: theoretical and experimental aspects, Eur. J. Pharm. Sci. 68 (2015) 137-143.
19. J.C. Birchall, et al., Microneedles in clinical practiceean exploratory study into the opinions of healthcare professionals and the public, Pharm. Res. 28 (1) (2011) 95-106.
20. M.I. Haq, et al., Clinical administration of microneedles: skin puncture, pain and sensation, Biomed. Microdevices 11 (1) (2009) 35-47.
21. P. Ghosh, N.K. Brogden, A.L. Stinchcomb, Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skin, J. Pharm. Sci. 103 (2) (2014) 652-660.
22. K. Cheung, D.B. Das, Microneedles for drug delivery: trends and progress, Drug Deliv. (2014) 1-17.
23. S. Indermun, et al., Current advances in the fabrication of microneedles for transdermal delivery, J. Control Release 185 (2014) 130-138.
24. Y.C. Kim, J.H. Park, M.R. Prausnitz, Microneedles for drug and vaccine delivery, Adv. Drug. Deliv. Rev. 64 (14) (2012) 1547-1568.
25. K. van der Maaden, W. Jiskoot, J. Bouwstra, Microneedle technologies for (trans)dermal drug and vaccine delivery, J. Control Release 161 (2) (2012) 645-655.
26. Gerstel MS, Place VA., US Patent US3964482. 1976.
27. M.R. Prausnitz, Microneedles for transdermal drug delivery, Adv. Drug Deliv. Rev. 56 (5) (2004) 581e587.
28. Y.C. Kim, J.H. Park, M.R. Prausnitz, Microneedles for drug and vaccine delivery, Adv. Drug Deliv. Rev. 64 (14) (2012) 1547-1568.
29. M.C. Chen, et al., Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination, Biomaterials 34 (12) (2013) 3077-3086.
30. R.F. Donnelly, et al., Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery, Adv. Funct. Mater. 22 (23) (2012) 4879-4890.
31. R.F. Donnelly, et al., Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet, Pharm. Res. 31 (8) (2014) 1989-1999.
32. L. Wei-Ze, et al., Super-short solid silicon microneedles for transdermal drug delivery applications, Int. J. Pharm. 389 (1-2) (2010) 122-129.
33. B.P. Chaudhri, et al., High strength, polymer microneedles for transdermal drug delivery, Procedia Eng. 25 (0) (2011) 1377-1380.
34. T.R.R. Singh, et al., 6-Microneedles for drug delivery and monitoring, in: X. Li, Y. Zhou (Eds.), Microfluidic Devices for Biomedical Applications, Woodhead Publishing, 2013, pp. 185-230.
35. R.F. Donnelly, et al., Microneedle-mediated intradermal delivery of 5- aminolevulinic acid: potential for enhanced topical photodynamic therapy, J. Control. Release 129 (3) (2008) 154-162.
36. E. Nuxoll, BioMEMS in drug delivery, Adv. Drug Deliv. Rev. 65 (11-12) (2013) 1611-1625.
37. M. Pearton, et al., Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations, Pharm. Res. 25 (2) (2008) 407-416.
38. J. Gupta, et al., Kinetics of skin resealing after insertion of microneedles in human subjects, J. Control Release 154 (2) (2011) 148-155.
39. K.T. Nguyen, K.B. I, S.J. Parikh, I.E. Popova, D.A. Bair, Transdermal delivery of captopril and metoprolol tartrate with microneedles, Drug Deliv. Lett. (2014). 236-243.
40. V.V. Yuzhakov, The AdminPenTM microneedle device for painless & convenient drug delivery, Drug Deliv.ery Technol. 10 (4) (2010) 32-36.
41. M.F. Aimi, et al., High-aspect-ratio bulk micromachining of titanium, Nat. Mater. 3 (2) (2004) 103-105.
42. H.-J. Choi, et al., Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles, J. Control. Release 166 (2) (2013) 159-171.
43. A.K. Andrianov, A. Marin, D.P. DeCollibus, Microneedles with intrinsic immunoadjuvant properties: microfabrication, protein stability, and modulated release, Pharm. Res. 28 (1) (2011) 58-65.
44. H.S. Gill, M.R. Prausnitz, Coated microneedles for transdermal delivery, J. Control Release 117 (2) (2007) 227-237.
45. Y.-C. Kim, et al., Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity, J. Control. Release 142 (2) (2010) 187-195.
46. K.B. Ita, N. H, V. Tolstikov, Microneedle-mediated delivery of atenolol and bisoprolol hemifumarate, J. Nanopharmaceutics Drug Deliv. 1 (1) (2013) 38-44.
47. S. Indermun, et al., Current advances in the fabrication of microneedles for transdermal delivery, J. Control. Release 185 (0) (2014) 130-138.
48. M. Verhoeven, et al., Applying ceramic nanoporous microneedle arrays as a transport interface in egg plants and an ex-vivo human skin model, Microelectron. Eng. 98 (0) (2012) 659-662.
49. A. Doraiswamy, et al., Fabrication of microneedles using two photon polymerization for transdermal delivery of nanomaterials, J. Nanosci. Nanotechnol. 10 (10) (2010) 6305-6312.
50. M. Domanski, et al., Production and characterization of miro- and nanofeatures in biomedical alumina and zirconia ceramics using a tape casting route, J. Mater. Sci. Mater. Med. 23 (7) (2012) 1637-1644.
51. L.Y. Chu, M.R. Prausnitz, Separable arrowhead microneedles, J. Control. Release 149 (3) (2011) 242-249.
52. J. Alexander, et al., (Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: increased permeation through biological membranes, J. Med. Chem. 31 (2) (1988) 318-322.
53. T.M. Tuan-Mahmood, M.T. McCrudden, B.M. Torrisi, E. McAlister, M.J. Garland, T.R. Singh, R.F. Donnelly, Microneedles for intradermal and transdermal drug delivery, Eur. J. Pharm. Sci. 50 (5) (2013) 623-637.
54. Uddin, M.J., et al., Inkjet printing of transdermal microneedles for the delivery of anticancer agents. Int. J. Pharm., (0).
55. X. Chen, et al., Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin, J. Control. Release 139 (3) (2009) 212-220.
56. Peter C. Demuth, X. S., Raymond E. Samuel, Paula T. Hammond, Darrell J. Irvine, Nano-layered microneedles for transcutaneous delivery of polymer nanoparticles and plasmid DNA, Adv. Mater. 22 (2010) 4851-4856.
57. J.S. Kochhar, et al., Effect of microneedle geometry and supporting substrate on microneedle array penetration into skin, J. Pharm. Sci. 102 (11) (2013) 4100-4108.
58. R.H.E. Chong, et al., Gene silencing following siRNA delivery to skin via coated steel microneedles: in vitro and in vivo proof-of-concept, J. Control. Release 166 (3) (2013) 211-219.
59. R.F. Donnelly, et al., Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety, Int. J. Pharm. 451 (1-2) (2013) 76-91.
60. R.F. Donnelly, et al., Hydrogel-forming microneedles increase in volume during swelling in skin, but skin barrier function recovery is unaffected, J. Pharm. Sci. 103 (5) (2014) 1478-1486.
61. R.F. Donnelly, et al., Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety, Int. J. Pharm. 451 (1-2) (2013) 76-91.
62. S. Indermun, R. Luttge, Y.E. Choonara, P. Kumar, L.C. du Toit, G. Modi, V. Pillay, Current advances in the fabrication of microneedles for transdermal delivery, J. Control Release. 185 (2014) 130-138.
63. X. Hong, et al., Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine, Drug Des. Devel Ther. (2013) 945-952.
64. S.P. Sullivan, et al., Dissolving polymer microneedle patches for influenza vaccination, Nat. Med. 16 (8) (2010) 915-920.
65. Q. Wang, et al., Investigation on fabrication process of dissolving microneedle arrays to improve effective needle drug distribution, Eur. J. Pharm. Sci. 66 (0) (2015) 148-156.
66. S.D. Gittard, et al., Two photon polymerization-micromolding of polyethylene glycol-gentamicin sulfate microneedles, Adv. Eng. Mater. 12 (4) (2010). B77-b82.
67. R.F. Donnelly, et al., Processing difficulties and instability of carbohydrate microneedle arrays, Drug Dev. Ind. Pharm. 35 (10) (2009) 1242-1254.
68. K. Lee, H. Jung, Drawing lithography for microneedles: a review of fundamentals and biomedical applications, Biomaterials 33 (30) (2012) 7309-7326.
69. J.D. Kim, et al., Droplet-born air blowing: novel dissolving microneedle fabrication, J. Control Release 170 (3) (2013) 430-436.
70. F. Cosman, et al., Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women, J. Clin. Endocrinol. Metab. 95 (1) (2010) 151-158.
71. G.W. Cleary, Microneedles for drug delivery, Pharm. Res. 28 (1) (2011) 1-6.
72. A.C. Anselmo, S. Mitragotri, An overview of clinical and commercial impact of drug delivery systems, J. Control. Release 190 (0) (2014) 15-28.
73. P.E. Daddona, et al., Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis, Pharm. Res. 28 (1) (2011) 159-165.
74. Y. Levin, E. Kochba, R. Kenney, Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: are all delivery methods the same? Vaccine 32 (34) (2014) 4249-4252.
75. Y. Zhang, et al., Adjuvants to prolong the local anesthetic effects of coated microneedle products, Int. J. Pharm. 439 (1-2) (2012) 187e192.
76. J. Gupta, E.I. Felner, M.R. Prausnitz, Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles, Diabetes Technol. Ther. 11 (6) (2009) 329-337.